(NewsDirect)
hVIVO chairman Cathal Friel joinedProactive's Stephen Gunnion to discuss the sale of shares in hVIVOPLC by directors, including himself.
Friel explained his decision to sell a portion of his shares inhVIVO was to accommodate the high demand from major institutions whileemphasising his commitment to remain a long-term, supportiveshareholder despite this sale.
Friel, who co-founded hVIVO (formerly known as Open Orphan) in2017, highlighted the company's significant growth and his activeinvolvement in its operations and strategic direction. He mentionedhis 25-year experience in mergers and acquisitions (M&A) and hisconfidence in the company's ability to surpass its medium-termrevenue target of £100 million, partly through strategic M&Aactivities.
Additionally, Friel talked about his new role asExecutive Chairman at Poolbeg, a company associated with hVIVO,assuring that this would not diminish his involvement with hVIVO. Heshared his enthusiasm for the future of both companies, underscoringhis role in identifying market opportunities and assemblinghigh-performing teams to capitalize on them.
ContactDetails
Proactive UK Ltd
+44 20 7989 0813
Copyright (c) 2024 TheNewswire - All rights reserved.